Although very few studies have compared the level of metabolic hormones in ALS patients and controls, Bilic et al. studied the differences in insulin, growth hormone, and insulin growth factor-1 (IGF-1) levels in ALS patients and healthy controls. This evidence concerns the gene INS and amyotrophic lateral sclerosis.